Skip to content
QCast: Data-Driven Dialogue in Drug Development podcast artwork

QCast: Data-Driven Dialogue in Drug Development

by Quanticate

QCast by Quanticate is the podcast for biotech, pharma, and life science leaders looking to deepen their understanding of biometrics and modern drug development. Join co-hosts Tom and Jullia as they explore methodologies, case studies, regulatory shifts, and industry trends shaping the future of clinical research. Where biometric expertise meets data-driven dialogue, QCast delivers practical insights and thought leadership to inform your next breakthrough.

From the show's RSS feed, refreshed Nov 13, 2026. Source feed.

Subscribe Bookmark

Episodes

  1. Episode 73: Respiratory Clinical Trials

    Respiratory clinical trials cover a wide spread of conditions, from asthma and COPD to idiopathic pulmonary fibrosis, chronic cough and Long COVID, and each one asks something different of a study design. In this QCast episode, co-hosts Jullia and Tom look at why endpoints such as FEV1, FVC,...

  2. Episode 72: Group Sequential Designs in Clinical Trials

    In this QCast episode, co-hosts Jullia and Tom discuss group sequential designs in clinical trials, where pre-planned interim analyses allow a study to stop early for efficacy, stop for futility, or continue to the next look. Key Takeaways Interim looks are usually timed by information fraction,...

  3. Episode 71: What is a Clinical Development Plan?

    A clinical development plan should connect the evidence a programme needs with its studies, decision points, regulatory interactions and resources. In this QCast episode, co-hosts Jullia and Tom examine how a well-structured CDP turns clinical development strategy into an executable programme,...

  4. Episode 70: Clinical Trial Planning and Design

    Clinical trial design decisions can have consequences across the protocol, analysis and delivery of a study. In this QCast episode, co-hosts Jullia and Tom examine how a clear research question should guide the study population, endpoints, comparator and statistical approach. Key Takeaways A...

  5. Episode 69: SDTM Mapping Automation Tool

    In this QCast episode, co-hosts Jullia and Tom examine how SDTM mapping automation tools use approved rules and metadata to generate mapping specifications and SAS code, and where AI can assist with unfamiliar variables. Key Takeaways Approved mappings can be reused across studies and updated…

    more
  6. Episode 68: AI in Clinical Trial Design

    AI and machine learning can help research teams make more informed clinical trial design decisions, from assessing protocol feasibility to identifying suitable patient populations. In this QCast episode, Jullia and Tom discuss how predictive modelling, natural language processing, and…

    more
  7. Episode 67: The Analysis of Direct and Indirect Pathways in Observational Studies

    In this episode, Jullia and Tom discuss direct and indirect pathways in observational studies, with a focus on mediation analysis and what it can, and cannot, show. Using an ankylosing spondylitis example, they look at how fatigue, anxiety/depression, and work productivity loss can be mapped as...

  8. Episode 66: What is Clinical Traceability?

    Clinical traceability is about being able to follow evidence from a reported result back to its source and understand the transformations, decisions, and records in between. In this QCast episode, co-hosts Jullia and Tom discuss how traceability can become harder when studies involve multiple...

  9. Episode 65: Clinical Trial Trends Shaping Modern Drug Development

    Clinical trial trends matter most when they affect how studies are designed, delivered, and overseen. In this QCast episode, co-hosts Jullia and Tom discuss how decentralised models, AI, real-world evidence, adaptive designs, RBQM, outsourcing, and digital trial systems are changing practical...

  10. Episode 64: Tipping Point Analysis in Clinical Trials

    Tipping point analysis helps trial teams understand how strongly a study conclusion depends on assumptions about missing data. In this QCast episode, co-hosts Jullia and Tom discuss how the method relates to MAR and MNAR, how delta adjustments can identify a tipping point, and why the numerical...

  11. Episode 63: Audit Trail Review in Clinical Trials

    Audit trail review can involve far more than checking whether a system records changes. In this QCast episode, co-hosts Jullia and Tom discuss how trial teams can decide what needs review, where risk should shape scope and timing, and why unusual activity needs context before it becomes a…

    more
  12. Episode 62: Drug Adherence and Persistence

    Drug adherence and persistence measures built from claims or EHR databases depend as much on study definitions as recorded treatment events. In this QCast episode, co-hosts Jullia and Tom explain how adherence differs from persistence, what prescribing and dispensing data can and cannot show, and...

  13. Episode 61: The Role of Data Monitoring Committees (DMC) in Clinical Trials

    In this QCast episode, Jullia and Tom discuss the role of data monitoring committees, or DMCs, in clinical trials. They explain how DMCs support participant safety and trial integrity, when independent monitoring may be proportionate, and why confidential interim data needs careful handling. Key...

  14. Episode 60: Oncology Phase 1 Trial Design

    In this QCast episode, Jullia and Tom discuss how oncology Phase 1 trial design has moved beyond simply identifying the maximum tolerated dose. They look at dose optimisation, escalation methods, simulation, data readiness, expansion cohorts, biomarkers and site capability, with a focus on how...

  15. Episode 59: Clinical Data Quality

    In this QCast episode, Jullia and Tom look at how clinical data quality is shaped from study set-up through collection, review and integration. They discuss why clear definitions, well-designed data flows and proportionate quality control matter, particularly when trial data move across multiple...

  16. Episode 58: Rescue Studies

    In this QCast episode, Jullia and Tom discuss how sponsors can assess a study in difficulty, decide how to handle existing databases and data, manage handovers, and set realistic expectations for recovery. Key Takeaways A rescue assessment should identify the root cause before corrective work...

  17. Episode 57: Clinical Trial Performance Metrics

    In this QCast episode, Jullia and Tom examine how clinical trial performance metrics can support better oversight without creating unnecessary reporting burden. They explain the difference between metrics and key performance indicators, why ownership is often shared across sponsors, CROs and…

    more
  18. Episode 56: Bayesian Clinical Trial Design

    In this QCast episode, co-hosts Jullia and Tom explain how priors, posterior probabilities and predictive probabilities support clinical decisions. They also discuss external data borrowing, adaptive trial features, simulation, regulatory expectations and the operational work needed to deliver...

  19. Episode 55: What is Adaptive Trial Design?

    In this QCast episode, Jullia and Tom examine how adaptive trial design allows pre-specified changes to a clinical trial using accumulating interim data. They look at common adaptations, including early stopping, sample size re-estimation and dose selection, while also addressing the statistical,...

  20. Episode 54: SAS vs R vs Python in Clinical Trials

    In this QCast episode, Jullia and Tom look at SAS vs R vs Python through the lens of clinical trial delivery. Rather than treating the choice as a programming preference, they focus on where each tool tends to fit: SAS for established clinical reporting, R for statistical analysis and...

  21. Episode 53: Decentralised Clinical Trials

    In this QCast episode, Jullia and Tom discuss decentralised clinical trials and what they mean for clinical development teams in practice. The episode looks at decentralisation as a spectrum of remote, local, digital, and site-based activity, rather than a move to fully virtual trials. Key...

  22. Episode 52: The Global Statistical Test for Multiple Endpoint Analysis

    In this QCast episode, Jullia and Tom discuss the Global Statistical Test for multiple endpoints analysis and why it can be useful when a clinical trial needs to assess more than one outcome at the same time. They cover the problem of testing endpoints separately, how GST supports an overall...

  23. Episode 51: CDASH Standards and Conformance in Clinical Data Management

    In this QCast episode, Jullia and Tom discuss CDASH standards and conformance in clinical data management, with a focus on where CDASH sits in the clinical data flow and why it matters before data reaches SDTM. The episode looks at CRF and eCRF design, naming conventions, metadata, controlled...

  24. Episode 50: Multi-Omics Application in Personalised Medicine Studies

    In this QCast episode, Jullia and Tom discuss multi-omics and its application in personalised medicine studies. The episode explains how genomic, transcriptomic, proteomic, metabolomic and other biological data layers can be analysed together to better understand disease, treatment response and...

  25. Episode 49: BIMO Listings

    In this QCast episode, Jullia and Tom discuss BIMO listings and their role in FDA inspection readiness. They explain how Bioresearch Monitoring looks at clinical trial conduct, participant protection, data credibility, and the records that support regulatory submissions. The episode also covers...

  26. Episode 48: Efficacy Endpoints in Oncology Clinical Trials

    In this QCast episode, Jullia and Tom discuss efficacy endpoints in oncology clinical trials and why endpoint choice shapes how treatment benefit is assessed. They look at overall survival, progression-free survival, objective response rate, disease-free survival, event-free survival, symptom...

  27. Episode 47: The Creation of ADaM Datasets for PK Analysis

    In this QCast episode, Jullia and Tom discuss how ADaM datasets are created for pharmacokinetic, or PK, analysis. They look at the role of ADPC for concentration data and ADPP for derived PK parameters, including how these datasets relate to SDTM PC and PP. The episode also covers why timing,...

  28. Episode 46: What is Clinical Data Review?

    In this QCast episode, Jullia and Tom discuss clinical data review as an active part of study oversight, rather than a late-stage clean-up exercise. They explore how timely, connected review supports subject safety, data quality, medical review and confident decision-making, especially as trial...

  29. Episode 45: Clinical Trial Management Systems (CTMS)

    In this QCast episode, Jullia and Tom discuss clinical trial management systems and their role in keeping clinical studies under control. They explain how CTMS differs from EDC, why operational visibility matters across recruitment, monitoring, site activity and documentation, and how a well-used...

  30. Episode 44: Clinical Trial Simulation

    In this QCast episode, co-hosts Jullia and Tom explore clinical trial simulation and how it supports better study design decisions before a trial begins. They explain how simulation uses statistical and mathematical models to test plausible study scenarios, rather than relying on a single fixed...

  31. Episode 43: Clinical Study Start Up

    In this QCast episode, co-hosts Jullia and Tom explore clinical study start up and why it has such a direct effect on how a trial runs once sites begin opening. They look at what study start up actually includes, from feasibility and budgeting to contracts, ethics, and regulatory submissions, and...

  32. Episode 42: Medical Device Clinical Trials

    In this QCast episode, Jullia and Tom explore medical device clinical trials and why they differ in important ways from drug studies. They explain what these trials are designed to show, how safety, performance, and clinical benefit are assessed across different types of devices, and why study...

  33. Episode 41: What Are SAD MAD Studies?

    In this QCast episode, Jullia and Tom explore SAD and MAD studies and why they play such a central role in early clinical development. They explain what single ascending dose and multiple ascending dose studies are designed to show, how they help teams build an early picture of safety,...

  34. Episode 40: Functional Service Provision (FSP)

    In this QCast episode, Jullia and Tom explore functional service provision and why it remains such an important outsourcing model in clinical development. They explain what FSP means in practical terms, how it differs from full-service delivery, where it can give sponsors more flexibility and...

  35. Episode 39: Automation in Clinical Trials

    In this QCast episode, Jullia and Tom explore automation in clinical trials and why it matters for modern study delivery. They explain what automation looks like in day-to-day trial work, where it can reduce manual burden across consent, data flow, query management, and oversight, and why its…

    more
  36. Episode 38: Observational Studies in Clinical Trials

    In this QCast episode, Jullia and Tom explore observational studies and why they remain such an important part of the evidence base in drug development. They explain what makes an observational study different from an interventional trial, how routine care data can be used to answer practical...

  37. Episode 37: Phase 2b in Clinical Trials

    In this QCast episode, Jullia and Tom explore phase 2b in clinical trials and why this stage plays such a decisive role in moving a programme towards phase 3. They explain how phase 2b is typically used to reduce uncertainty around dose, population, endpoints, and treatment effect, and why the...

  38. Episode 36: ACR Response Criteria in Rheumatoid Arthritis Trials

    In this QCast episode, Jullia and Tom unpack ACR response criteria in rheumatoid arthritis clinical trials and why these endpoints are more operationally demanding than they look on paper. They explain what ACR20, ACR50, and ACR70 measure, how the responder definition depends on consistent joint...

  39. Episode 35: Regulatory Submissions in Clinical Trials

    In this QCast episode, Jullia and Tom explore regulatory submissions in clinical trials and why strong submission discipline protects timelines long before any scientific review begins. They discuss what a regulatory submission includes in practice, how early technical validation and portal...

  40. Episode 34: Therapeutic Areas in Clinical Research

    In this QCast episode, Jullia and Tom unpack therapeutic areas in clinical research and why they matter far beyond a clinical label. They discuss how a therapeutic area shapes trial design assumptions, from endpoint selection and safety oversight to site models, specialist assessments, and the…

    more
  41. Episode 33: eCRF Design in Clinical Trials

    In this QCast episode, Jullia and Tom break down eCRF design in clinical trials and why it has such an outsized impact on data quality, site workload, and downstream analysis. They clarify what an electronic case report form is meant to do in practice, how it translates protocol requirements into...

  42. Episode 32: Risk-Based Quality Management in CDM

    In this QCast episode, Jullia and Tom unpack risk-based quality management (RBQM) in clinical data management and why it’s central to protecting participant safety and the reliability of trial results. They clarify what RBQM means in practice, how teams identify critical data and processes, and…

    more
  43. Episode 31: Investigator's Brochure (IB)

    In this QCast episode, Jullia and Tom break down the Investigator’s Brochure (IB) and why it remains a cornerstone of safe, consistent trial conduct. They explain what an IB is, who relies on it, and how it complements the protocol by translating the evolving evidence base into practical guidance...

  44. Episode 30: Adaptive Randomisation in Clinical Trials

    In this QCast episode, Jullia and Tom unpack adaptive randomisation in clinical trials and why teams consider it when fixed allocation feels inefficient or ethically uncomfortable. They explain how response-adaptive randomisation can shift treatment assignment as evidence accumulates, and how...

  45. Episode 29: What is Clinical Data Management?

    In this QCast episode, Jullia and Tom break down what clinical data management is and why it’s essential to reliable trial decisions. They explain how clinical data management supports patient safety and data integrity from study start-up through to database lock, covering core activities like…

    more
  46. Episode 28: Real World Data Analysis in Clinical Trials

    In this QCast episode, Jullia and Tom unpack how real world data is analysed to complement clinical trials. They clarify the difference between real world data and real world evidence, explore the main data sources and their trade-offs, and explain how these datasets support trial decisions…

    more
  47. Episode 27: Machine Learning in the Pharmaceutical Industry

    In this QCast episode, Jullia and Tom unpack how machine learning is being applied across the pharmaceutical industry. They discuss what machine learning means in a regulated drug development context, where it is already supporting discovery, development, and trial operations, and how teams can…

    more
  48. Episode 26: Medical Coding in Clinical Data Management

    In this QCast episode, Jullia and Tom explore medical coding in clinical data management, clarifying how clinical narratives are translated into standardised terminology, why consistent coding underpins safety review and regulatory confidence, and how coding decisions shape analysis-ready…

    more
  49. Episode 25: The Proportional Odds Assumption in Clinical Trials

    In this QCast episode, Jullia and Tom unpack the proportional odds assumption in ordinal logistic regression, explaining what it means in practice, why it matters for ordinal endpoints in clinical trials, and how to diagnose and handle violations without losing the value of ordered scales. Key...

  50. Episode 24: Health Economics and Outcomes Research (HEOR)

    In this QCast episode, Jullia and Tom explore health economics and outcomes research, explaining how outcomes research looks beyond controlled trials to real world care and how HEOR evidence informs pricing, reimbursement, and access decisions. Key Takeaways Anchor HEOR work to a clear decision...

About this show

QCast by Quanticate is the podcast for biotech, pharma, and life science leaders looking to deepen their understanding of biometrics and modern drug development. Join co-hosts Tom and Jullia as they explore methodologies, case studies, regulatory shifts, and industry trends shaping the future of clinical research. Where biometric expertise meets data-driven dialogue, QCast delivers practical insights and thought leadership to inform your next breakthrough.

Hosted by

Quanticate

Categories

Frequently asked questions

How many episodes does QCast: Data-Driven Dialogue in Drug Development have?

QCast: Data-Driven Dialogue in Drug Development has 72 episodes on PodParley. The most recent episode was published on November 20, 2026.

What is QCast: Data-Driven Dialogue in Drug Development about?

QCast by Quanticate is the podcast for biotech, pharma, and life science leaders looking to deepen their understanding of biometrics and modern drug development. Join co-hosts Tom and Jullia as they explore methodologies, case studies, regulatory shifts, and industry trends shaping the future of...

How often does QCast: Data-Driven Dialogue in Drug Development release new episodes?

QCast: Data-Driven Dialogue in Drug Development publishes weekly, based on its 72 episodes since June 2025.

Who hosts QCast: Data-Driven Dialogue in Drug Development?

QCast: Data-Driven Dialogue in Drug Development is created and hosted by Quanticate.
Link copied